Clinical Trials
Study Title:
A Randomized Phase III Trial of Intravesical BCG veRsus Intravesical Docetaxel and GEmcitabine Treatment in BCG Naïve High Grade Non Muscle Invasive Bladder Cancer (BRIDGE)
|
For more information about the trial above please contact the study team:
Medical University of South Carolina
Affiliate Principal Investigator, Stephen Savage, at savages@musc.edu.
Principal Investigator, Stephen Savage, at savages@musc.edu.
Study Coordinator, Renee Tucker, at tuckerr@musc.edu.
Ralph H. Johnson VAMC
Study Coordinator, Kathy Jeter, at katherine.jeter2@va.gov.
Trial opened at the following institutions: Medical University of South Carolina, Ralph H. Johnson VAMC |